Diagnosis and management of gestational trophoblastic disease: 2025 update
International Journal of Gynecology & Obstetrics · 2025-09 · 171 (S1) · 78-86
DOI: 10.1002/ijgo.70275 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Gynecology & Obstetrics, online erschienen am 09.07.2025. Verfasst von Hextan Y S Ngan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, University of Hong Kong, Queen Mary Hospital, Hong Kong, China. Hauptthemen laut MEDLINE: Gestational Trophoblastic Disease. Die Arbeit wurde bisher 72-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Gestational trophoblastic disease (GTD) arises from abnormal placenta and comprises a spectrum of premalignant to malignant disorders. Changes in the epidemiology of GTD have been noted in various countries. In addition to histology, molecular genetic studies can help in the diagnostic pathway. Earlier detection of molar pregnancy by ultrasound has resulted in changes in clinical presentation and decreased morbidity from uterine evacuation. Follow‐up with human chorionic gonadotropin (hCG) is essential for early diagnosis of gestational trophoblastic neoplasia (GTN). The duration of hCG monitoring varies depending on histological type and regression rate. Low‐risk GTN (International Federation of Gynecology and Obstetrics [FIGO] Stages I–III: score
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, University of Hong Kong, Queen Mary Hospital, Hong Kong, China.
- Department of Medical Oncology, Charing Cross Trophoblastic Disease Center, Charing Cross Campus of Imperial College London, London, UK.
- Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- French Trophoblastic Disease Reference Centre, Department of Obstetrics and Gynecology, Lyon University Hospital, Claude Bernard Lyon 1 University, Lyon, France.
- Department of Obstetrics and Gynecology, Institute of Maternal and Child Health, Medical College, Calicut, India.
ORCID-Profile: Hextan Y S Ngan
Zitieren
APA
Ngan, H. Y. S., Seckl, M. J., Berkowitz, R. S., Xiang, Y., Golfier, F., Sekharan, P. K., Braga, A., & Garrett, A. (2025). Diagnosis and management of gestational trophoblastic disease: 2025 update. International Journal of Gynecology & Obstetrics, 171(S1), 78-86. https://doi.org/10.1002/ijgo.70275
Vancouver
Ngan HYS, Seckl MJ, Berkowitz RS, Xiang Y, Golfier F, Sekharan PK, et al. Diagnosis and management of gestational trophoblastic disease: 2025 update. International Journal of Gynecology & Obstetrics. 2025;171(S1):78-86. doi:10.1002/ijgo.70275
BibTeX
@article{Ngan2025,
author = {Ngan, Hextan Y S and Seckl, Michael J and Berkowitz, Ross S and Xiang, Yang and Golfier, François and Sekharan, Paradan K and Braga, Antonio and Garrett, Andrea},
title = {Diagnosis and management of gestational trophoblastic disease: 2025 update},
journal = {International Journal of Gynecology & Obstetrics},
year = {2025},
volume = {171},
number = {S1},
pages = {78--86},
doi = {10.1002/ijgo.70275}
}
EUVIMED